Summary
University of Massachusetts (UMASS), formerly Massachusetts State College is a research university that offers graduate, undergraduate, summer courses, professional and distance learning programs. The university conducts research activities in areas of clinical and translational science, food science, other life sciences, environmental science, bioinformatics, marine science and bio-engineering, cell engineering, computer networking, nanotechnology, alternative energy, advanced materials and nanotech manufacturing. It provides educational services through UmassOnline which is an online education consortium that offers marketing support and services for online degree and certificate programs. The university offers online courses in academic disciplines which include education, IT, management, criminal justice, nursing, public health, hospitality and tourism, and liberal arts. It partners with Commonwealth of Massachusetts and Massachusetts department of higher education. The university is located in Worcester, Boston, Amherst, Datrtmouth and lowell. UMASS is headquartered in Shrewsbury, Massachusetts, the US.
University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Massachusetts, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Massachusetts, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
University of Massachusetts, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Spark Therapeutics Enters into partnership with University of Massachusetts Medical School 11
AbCellera Biologics Partners with MassBiologics 12
Quad Technologies Partners with University of Massachusetts Medical School 13
Grifols Enters into Agreement with MassBiologics 14
Anika Therapeutics Enters into Research Agreement with University of Massachusetts Amherst 15
Lysogene Enters into Agreement with University of Massachusetts Medical School and Auburn University 16
Voyager Therapeutics Enters into Agreement with MassBiologics 17
UMass Enters Into An Agreement With UOT, Tampere Institute, VTT, University Of Ulster And Queen's University 18
University Of Massachusetts Forms Joint Venture With UK Stem Cell 20
Lundbeck Enters Into Collaboration With The University Of Massachusetts 21
BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School 23
RXi Pharma Enters Into Co-Development Agreement With The UMMS 24
Licensing Agreements 25
ImmuCell Enters into Option Agreement with University of Massachusetts Amherst to License New Bacteriocin Technology 25
Amarantus Bioscience Enters Into Option For Licensing Agreement With University of Massachusetts 26
Voyager Therapeutics Enters into Licensing Agreement with University of Massachusetts 27
Amarantus Bioscience Enters Into Licensing Agreement With University of Massachusetts Medical School 29
University of Massachusetts Medical School Enters Into Licensing Agreement With Agalimmune For Alphaject 30
UMass Lowell Enters into Licensing Agreement with Sevo Nutraceuticals for Cognitive Function Nutritional Supplements 32
The University of Massachusetts Medical Enters Into Licensing Agreement With Merck 33
Asset Transactions 35
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 35
University of Massachusetts - Key Competitors 37
Key Employees 38
Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
University of Massachusetts, Pharmaceuticals & Healthcare, Key Facts 1
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Massachusetts, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Massachusetts, Deals By Therapy Area, 2010 to YTD 2016 8
University of Massachusetts, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Spark Therapeutics Enters into partnership with University of Massachusetts Medical School 11
AbCellera Biologics Partners with MassBiologics 12
Quad Technologies Partners with University of Massachusetts Medical School 13
Grifols Enters into Agreement with MassBiologics 14
Anika Therapeutics Enters into Research Agreement with University of Massachusetts Amherst 15
Lysogene Enters into Agreement with University of Massachusetts Medical School and Auburn University 16
Voyager Therapeutics Enters into Agreement with MassBiologics 17
UMass Enters Into An Agreement With UOT, Tampere Institute, VTT, University Of Ulster And Queen's University 18
University Of Massachusetts Forms Joint Venture With UK Stem Cell 20
Lundbeck Enters Into Collaboration With The University Of Massachusetts 21
BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School 23
RXi Pharma Enters Into Co-Development Agreement With The UMMS 24
ImmuCell Enters into Option Agreement with University of Massachusetts Amherst to License New Bacteriocin Technology 25
Amarantus Bioscience Enters Into Option For Licensing Agreement With University of Massachusetts 26
Voyager Therapeutics Enters into Licensing Agreement with University of Massachusetts 27
Amarantus Bioscience Enters Into Licensing Agreement With University of Massachusetts Medical School 29
University of Massachusetts Medical School Enters Into Licensing Agreement With Agalimmune For Alphaject 30
UMass Lowell Enters into Licensing Agreement with Sevo Nutraceuticals for Cognitive Function Nutritional Supplements 32
The University of Massachusetts Medical Enters Into Licensing Agreement With Merck 33
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 35
University of Massachusetts, Key Competitors 37
University of Massachusetts, Key Employees 38
University of Massachusetts, Subsidiaries 39
List of Figures
University of Massachusetts, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Massachusetts, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Massachusetts, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
